The primary efficacy variable in this INSIGHT study is the percentage of subjects with at least a 3-line improvement.~The secondary efficacy variable is the percentage of subjects who achieve a 2-line or greater improvement from pre-treatment.
To evaluate the safety and effectiveness of Aceclidine/Brimonidine (LNZ101) compared with Aceclidine (LNZ100) and vehicle in the treatment of Presbyopia.